GOSSELIES, Belgium--(BUSINESS WIRE)--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, organized on December 18 ...

Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...

BUFFALO, NY- March 20, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on February 11, 2023, entitled, “Unlocking the potential of molecular-driven stratification for osteosarcoma ...

Bone sarcomas are rare diseases in which cancerous cells form in the bone. These types of cancers are seen most often in children and young adults. Here are some of the bone sarcomas we diagnose and ...

Osteosarcoma and Ewing sarcoma are two types of bone cancer primarily affecting children and young adults. While both types of cancer originate in bone tissue, their symptoms, treatment, and location ...

Osteosarcoma is the most prevalent primary malignant bone tumor in children and adolescents. The current standard treatment involves a combination of chemotherapy and radical surgical resection. This ...

A major driver of the bone cancer osteosarcoma has been discovered by researchers from UCL, EMBL EBI and the Royal National Orthopaedic Hospital, providing insights that could help to predict cancer ...

Herein, we report a 73-year-old man with an acquired ALK-rearranged osteosarcoma. With targeted therapy, the patient showed prolonged disease stabilization of his previously progressing tumor.